UnitedHealth Group Incorporated $UNH Holdings Cut by 8 Knots Management LLC

Key Points

• 8 Knots Management LLC reduced its holdings in UnitedHealth Group by 42.2%, now owning 168,923 shares valued at approximately $88.47 million, making it the firm’s second largest investment.
• UnitedHealth Group reported $4.08 earnings per share, missing the consensus estimate of $4.45, with revenues of $111.62 billion for the quarter.
• The company announced a quarterly dividend of $2.21 per share, which will be paid on September 23, representing a dividend yield of 2.9%.

8 Knots Management LLC trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 42.2% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 168,923 shares of the healthcare conglomerate's stock after selling 123,313 shares during the quarter. UnitedHealth Group makes up approximately 11.2% of 8 Knots Management LLC's investment portfolio, making the stock its 2nd biggest holding. 8 Knots Management LLC's holdings in UnitedHealth Group were worth $88,473,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of UNH. Brighton Jones LLC lifted its position in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after acquiring an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC grew its position in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after purchasing an additional 2,324 shares during the last quarter. ArrowMark Colorado Holdings LLC purchased a new stake in UnitedHealth Group during the 4th quarter worth approximately $1,467,000. Ameriprise Financial Inc. grew its position in UnitedHealth Group by 2.2% during the 4th quarter. Ameriprise Financial Inc. now owns 4,679,266 shares of the healthcare conglomerate's stock worth $2,367,991,000 after purchasing an additional 100,753 shares during the last quarter. Finally, Algert Global LLC grew its position in UnitedHealth Group by 5.3% during the 4th quarter. Algert Global LLC now owns 3,175 shares of the healthcare conglomerate's stock worth $1,606,000 after purchasing an additional 160 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Up 2.5%

UnitedHealth Group stock opened at $309.77 on Monday. The stock has a market capitalization of $280.55 billion, a PE ratio of 13.42, a price-to-earnings-growth ratio of 2.00 and a beta of 0.44. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The business has a 50 day simple moving average of $288.16 and a 200-day simple moving average of $379.63. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business's revenue was up 12.9% compared to the same quarter last year. During the same quarter last year, the business earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on UNH shares. Barclays reissued an "overweight" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Wolfe Research lowered their price objective on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 20th. KeyCorp lowered their price target on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Truist Financial lowered their price target on shares of UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating on the stock in a report on Wednesday, July 16th. Finally, Oppenheimer lowered their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a report on Wednesday, July 30th. Fifteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of "Moderate Buy" and a consensus target price of $353.00.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.28% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.